An Open Study of ASP8273 in Patients With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations
Clinical trial NCT02192697 · TERMINATED
Trial details
- NCT number
- NCT02192697
- Sponsor
- Astellas Pharma Inc
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-23
- Primary completion
- 2016-01-15
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.